ArticleThe New England journal of medicine2015
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
Hans C Hasselbalch et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleThe New England journal of medicine2015
Hans C Hasselbalch et al.PubMed ↗Publisher ↗
No numbers read from the abstract.